These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31779212)

  • 1. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
    Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
    Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
    Pujals M; Resar L; Villanueva J
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
    Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
    PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
    Sgubin M; Pegoraro S; Pellarin I; Ros G; Sgarra R; Piazza S; Baldassarre G; Belletti B; Manfioletti G
    Cell Death Dis; 2022 May; 13(5):429. PubMed ID: 35504904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in Breast Cancer Cells.
    Petrosino S; Pacor S; Pegoraro S; Gazziero VA; Canarutto G; Piazza S; Manfioletti G; Sgarra R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
    Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
    Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells.
    Resmini G; Rizzo S; Franchin C; Zanin R; Penzo C; Pegoraro S; Ciani Y; Piazza S; Arrigoni G; Sgarra R; Manfioletti G
    Sci Rep; 2017 Sep; 7(1):11768. PubMed ID: 28924209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
    Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
    Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic mitochondrial localization of nuclear transcription factor HMGA1.
    Dement GA; Treff NR; Magnuson NS; Franceschi V; Reeves R
    Exp Cell Res; 2005 Jul; 307(2):388-401. PubMed ID: 15893306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
    Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
    Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranuclear Translocation of High-Mobility Group A1 Reduces the Invasion of Extravillous Trophoblasts Involved in the Pathogenesis of Preeclampsia: New Aspect of High-Mobility Group A1.
    Uchikura Y; Matsubara K; Muto Y; Matsubara Y; Fujioka T; Matsumoto T; Sugiyama T
    Reprod Sci; 2017 Dec; 24(12):1630-1638. PubMed ID: 28345487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
    Han X; Cao Y; Wang K; Zhu G
    Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
    J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.
    Tolza C; Bejjani F; Evanno E; Mahfoud S; Moquet-Torcy G; Gostan T; Maqbool MA; Kirsh O; Piechaczyk M; Jariel-Encontre I
    Mol Cancer Res; 2019 Oct; 17(10):1999-2014. PubMed ID: 31300541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer.
    Fiscon G; Pegoraro S; Conte F; Manfioletti G; Paci P
    FEBS Lett; 2021 Jun; 595(11):1569-1586. PubMed ID: 33835503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.